Implantable therapeutic delivery system having a nanofibrous core
Disclosed are an implantable therapeutic delivery system and methods of treatment utilizing the implantable therapeutic delivery system. The implantable therapeutic delivery system includes a nanofibrous core substrate including one or more internal spaces wherein one or more therapeutic agents is positioned in the one or more internal spaces; and an outer biocompatible polymeric coating surrounding said nanofibrous core substrate.
1. An implantable therapeutic delivery system comprising:
a nanofibrous core substrate comprising one or more internal spaces wherein one or more therapeutic agents is positioned in the one or more internal spaces; and
an outer biocompatible polymeric coating surrounding said nanofibrous core substrate,
wherein the nanofibrous core substrate contains divalent cations.
2. The implantable therapeutic delivery system according to claim 1 , wherein the nanofibrous core substrate and the outer biocompatible polymeric coating are crosslinked to each other.
3. The implantable therapeutic delivery system according to claim 1 , wherein the one or more therapeutic agents is insulin.
4. The implantable therapeutic delivery system according to claim 1 , wherein the one or more therapeutic agents is released from a preparation of cells positioned in the one or more internal spaces of the nanofibrous core substrate.
5. The implantable therapeutic delivery system according to claim 4 , wherein the preparation of cells is a preparation of islet cells that release insulin.
6. The implantable therapeutic delivery system according to claim 4 , wherein the preparation of cells is a preparation of stem cells or stem cell derived cells.
7. The implantable therapeutic delivery system according to claim 4 , wherein the one or more therapeutic agents is fibrinogen or Factor VIII.
8. The implantable therapeutic delivery system according to claim 1 further comprising:
one or more therapeutic agents positioned in the outer biocompatible polymeric coating surrounding said nanofibrous core substrate.
9. The implantable therapeutic delivery system according to claim 1 , wherein the one or more internal spaces comprises two or more discrete compartments.
10. The implantable therapeutic delivery system according to claim 1 , wherein the nanofibrous core substrate is formed by electro-spinning fibers of core material into a porous, shaped article defining the one or more internal spaces.
11. The implantable therapeutic delivery system according to claim 1 , wherein the outer biocompatible polymeric coating is a hydrogel material.
12. The implantable therapeutic delivery system according to claim 11 , wherein the hydrogel material comprises alginate.
13. The implantable therapeutic delivery system according to claim 1 , wherein the nanofibrous core substrate comprises a material selected from the group consisting of nylon, silk, poly(ether sulfone), polypropylene, polyester, polybutester, gelatin, chitosan, hyaluronic acid, silk fibroin, collagen, poly(lactic acid), polyurethane, polycarbonate, polyethylene, polydimethylsiloxane, polymethylmethacrylate, poly(ε-caprolactone), poly(lactic-co-glycolic acid), poly(ethylene-co-vinylacetate), and poly(l-lactide-co-ε-caprolactone).